Sumitomo Life Insurance Co. Buys Shares of 28,700 Nutrien Ltd. $NTR

Sumitomo Life Insurance Co. bought a new stake in Nutrien Ltd. (NYSE:NTRFree Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 28,700 shares of the company’s stock, valued at approximately $1,806,000.

Other large investors have also modified their holdings of the company. Guggenheim Capital LLC increased its position in shares of Nutrien by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after purchasing an additional 145 shares during the last quarter. Minot DeBlois Advisors LLC raised its holdings in Nutrien by 1.8% in the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock valued at $557,000 after buying an additional 164 shares during the period. Banque Cantonale Vaudoise lifted its position in Nutrien by 15.9% in the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after buying an additional 164 shares during the last quarter. Gould Asset Management LLC CA lifted its position in Nutrien by 4.4% in the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock valued at $297,000 after buying an additional 165 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after buying an additional 176 shares during the period. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Price Performance

Nutrien stock opened at $75.36 on Friday. The firm has a market cap of $36.05 billion, a PE ratio of 15.26, a price-to-earnings-growth ratio of 0.73 and a beta of 0.61. Nutrien Ltd. has a 52-week low of $53.03 and a 52-week high of $85.36. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36. The company’s 50 day moving average is $66.42 and its two-hundred day moving average is $70.42.

Nutrien (NYSE:NTRGet Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The business had revenue of $10.81 billion during the quarter, compared to analyst estimates of $10.44 billion. During the same quarter last year, the firm earned $2.65 EPS. The business’s revenue was up 3.6% on a year-over-year basis. On average, research analysts expect that Nutrien Ltd. will post 5.01 EPS for the current fiscal year.

Nutrien Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 dividend on an annualized basis and a yield of 2.9%. Nutrien’s dividend payout ratio (DPR) is 44.53%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. UBS Group dropped their price target on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. Bank of America upgraded shares of Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective on the stock in a report on Thursday, April 30th. Raymond James Financial raised shares of Nutrien from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $74.00 to $90.00 in a research report on Tuesday, May 5th. BNP Paribas Exane upgraded shares of Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 target price for the company in a report on Tuesday, July 28th. Finally, Berenberg Bank set a $65.00 target price on shares of Nutrien and gave the company a “hold” rating in a report on Wednesday, June 10th. Seventeen investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $81.58.

View Our Latest Stock Analysis on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.